Orthocell reports 98.6% success rate in Striate+™ dental membrane study

Orthocell Ltd (ASX:OCC, OTC:ORHHF) CEO and managing director Paul Anderson joins Jonathan Jackson in the Proactive studio to talk through a 98.6% success...

Related Keywords

Paul Anderson ,Jonathan Jackson ,Orthocell Ltd ,European Association For Osseintegration ,European Association ,European Medical Device Regulations ,Post Market Clinical Follow Up ,